AAIPharma Services Corp. and Cambridge Major Laboratories, Inc. are now Alcami

Originally joined together in late 2013, AAI and CML combined to offer analytical testing and development services for APIs with oral solid and parenteral dose finished product capacity. Providing an integrated offering for both drug substance and drug product at every development stage beginning with solid state chemistry and formulation development, Alcami believes they have created a robust new outsourcing offering.

Alcami has recently announced significant investments in additional capabilities and capacity for oral solid dose manufacturing, and parenteral fill-finish capabilities and capacity, including additional sterile lines and lyophilization capacity available now. Additionally, Alcami will be relocating its current St Louis Analytical Testing Services to a new state-of-the-art facility at the Cortex Innovation Center in St Louis, MO, which provides innovative analytical testing solutions for manufacturers' new drug entities, generic drugs, animal health products, medicated consumer health products, chemicals and biopharmaceuticals.

Stephan Kutzer, CEO, stated: "With nearly 1000 employees at seven sites in the US and Europe, these upgrades across our facilities in Wilmington, Charleston, Durham, Germantown, Edison, St Louis, and Weert, the Netherlands, combined with enhancements in our quality, execution and customer focus, support the overall progress of our growth strategy as a contract services provider with a renewed commitment to meeting customer needs like never before. With increases in our capabilities and capacities across all our businesses, our ability to serve the market is stronger than ever."